KBKatarzyna Barczyńska

Katarzyna Barczyńska

*This is an algorithmically generated author record based on publicly available information.

Katarzyna Barczyńska has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Common and Rare Complications of Lichtenstein Inguinal Hernioplasty

    by Aleksandra Grelowska, Adrian Ołubiec, Aleksandra Oto, Rafał Ejsner, Julia Kaczmarek, Katarzyna Barczyńska, Michał Błażuk, Nela Poznańska, Tomasz Sys

    Inguinal hernia repair remains one of the most frequently performed surgical procedures globally, with approximately 20 million operations conducted annually. While the Lichtenstein tension-free technique using polypropylene mesh is considered the "gold standard" due to its low recurrence rates and high safety profile, the procedure is still associated with a spectrum of potential complications. The most common among these include localized hematomas, seromas, surgical site infections and chronic pain. Furthermore, surgical manipulation within the spermatic cord may result in significant testicular complications. Certain outcomes, such as mesh migration or late-onset infections, may arise many years following the initial intervention. The primary strategy for mitigating these issues lies in the meticulous selection and execution of appropriate operative techniques. Rehabilitation includes early mobilization to the restoration of full physical activity. This study aims to provide a comprehensive review of the diverse range of complications associated with Lichtenstein inguinal hernioplasty.

  • Open Access

    Physical Activity and Other Strategies in Treatment of Buerger’s Disease - a Systematic Review

    by Julia Kaczmarek, Michał Błażuk, Katarzyna Barczyńska, Rafał Ejsner, Aleksandra Grelowska, Adrian Ołubiec, Aleksandra Oto, Nela Poznańska, Tomasz Sys

    Buerger's disease, also known as Thromboangitis obliterans (TAO), is a nonatherosclerotic vascular disorder of unknown etiology, causing distal arterial occlusions. Implication of changes in the vessels is decreased blood flow and ischemia as the result. Buerger’s disease is entirely associated with smoking. Diagnosis of TAO is challenging. Multiple diagnostic criteria have been suggested in the past years. Therefore it is advisable to base diagnosis on unified Delphi criteria. Patients suffering from TAO may present pain in digits as an early symptom, whereas late symptoms may include ulcers, gangrene and intermittent claudication. Current management of TAO lacks standard guidelines. There is no one satisfying strategy, which can be implemented in every single patient. Various conservative and surgical methods might be performed. Each one has its own advantages and disadvantages. To this very day, tobacco cessation is the cornerstone of the treatment. Important, although frequently neglected aspect is an exercise therapy. Modern, satisfying treatment methods are constantly explored.

  • Open Access

    The Surgical and conservative treatment of pectus excavatum

    by Rafal Ejsner, Katarzyna Barczyńska, Aleksandra Grelowska, Aleksandra Oto, Adrian Ołubiec, Tomasz Sys, Ewa Gloc, Aleksandra Bilińska, Dominika Dmowska, Michał Błażuk, et al.

    Pectus excavatum is one of the most common chest defect in children. It is characterized by a collapsed sternum, reduced thoracic volume and cardiovascular and respiratory symptoms. In order to determine the degree of deformation and its type, diagnostic management is necessary, including imaging tests such as CT scans, from which the degree and nature of the defect can be determined, as well as other tests to determine the impact of the defect on the patient's functioning. Treatment options include non-invasive methods and invasive methods such as the minimally invasive Nuss procedure or Ravitch procedure. The gold standard of treatment is the Nuss procedure, but in some cases, conservative treatment may be an alternative. Each method has its advantages and disadvantages, and the treatment method is selected after talking to the patient, determining his expectations, age, severity of the defect and its nature.

  • Open Access

    Liraglutide – Effects on Lean Body Mass, Muscle Mass and Prevention of Muscle Loss. A Comprehensive Literature Review

    by Michał Oborski, Krzysztof Oborski, Szymon Górski, Joanna Okupniarek, Maria Ochwat, Michalina Bartosik, Igor Jętasiewicz, Jakub Miarczyński, Paweł Piechocki, Katarzyna Barczyńska

    Introduction and Purpose. Obesity is a major global health challenge, requiring effective long-term treatments. Liraglutide, a GLP-1 agonist, is effective for weight loss and reducing visceral fat. However, its impact on lean body mass (LBM) and muscle mass is crucial, as their loss can lead to sarcopenia, metabolic impairment, and weight regain. Therefore, this literature review systematically analyses liraglutide's effects on LBM and muscle mass in obesity and/or type 2 diabetes, and presents strategies to minimise potential muscle loss during therapy. Materials and methods. A systematic review of the scientific literature was conducted. Literature available in the PubMed and Google Scholar databases was searched using keywords. Results. The findings from clinical trials are not definitive. While several studies report a statistically significant loss of lean body mass (LBM), it remains proportionally smaller than fat loss and may constitute up to 40% of total weight reduction. Conversely, other studies—including the most recent ones—indicate that liraglutide primarily reduces adipose tissue. This effect preserves LBM and can enhance muscle quality by reducing intramuscular fat. The observed absolute decrease in LBM appears strongly correlated with total weight loss, implying it is a consequence of weight reduction itself rather than a specific drug-induced catabolic effect. Preliminary data also suggest liraglutide may have a direct anabolic and protective effect on skeletal muscle via modulation of signalling pathways. To mitigate muscle loss, pharmacotherapy should be combined with non-pharmacological interventions, such as a high-protein diet (1.2–1.6 g/kg bw/day) and regular resistance training. Combination therapies including anabolic agents also represent a promising approach.


  • Open Access

    Pathophysiology of Decompression Sickness: Current Insights and Emerging Models

    by Jakub Miarczyński, Szymon Górski, Joanna Okupniarek, Michalina Bartosik, Igor Jętasiewicz, Michał Oborski, Krzysztof Oborski, Katarzyna Barczyńska

    Introduction: Decompression sickness (DCS), commonly known as “the bends,” is a clinical disorder caused by the formation of gas bubbles within tissues or the bloodstream as a result of inert gas supersaturation during or following a decrease in ambient pressure. It most often occurs in the setting of compressed-gas diving, work in pressurized environments such as caissons, or rapid decompression to high altitude, including situations involving reduced cabin pressure or extravehicular activity (EVA) in space suits. DCS may also develop after relatively modest pressure reductions, such as commercial air travel undertaken shortly after scuba diving. Clinical manifestations vary widely, ranging from musculoskeletal pain, lymphedema, and cutaneous rashes to severe neurological deficits and cardiorespiratory collapse. Initial evaluation should include a detailed history of recent diving or altitude exposure, the timing of symptom onset, and a thorough neurological examination. Immediate management consists of high-flow oxygen administration and appropriate fluid resuscitation, either orally or intravenously. Definitive treatment involves hyperbaric oxygen therapy. Although residual symptoms may persist in severe cases, prompt and appropriate treatment generally leads to a favorable outcome.

  • Open Access

    Vitamin D in Injury Risk and Healing- A Comprehensive Review

    by Igor Jętasiewicz, Szymon Górski, Joanna Okupniarek, Michalina Bartosik, Michał Oborski, Krzysztof Oborski, Jakub Miarczyński, Katarzyna Barczyńska

    In an era of an aging population, vitamin D deficiencies constitute a significant clinical problem. Its pleiotropic effects encompass key reparative processes in soft and bone tissues, as well as modulation of the nervous and immune systems, suggesting its potentially important role in injury prevention and healing support. The aim of this review was to systematically analyse and synthesise current knowledge regarding: (1) the molecular mechanisms of vitamin D action in repair processes, (2) the efficacy of its supplementation in the context of post-injury healing, and (3) the clinical consequences of its deficiency. The literature review was conducted according to the PRISMA methodology. The PubMed, Scopus, and Web of Science databases were searched using defined keywords related to vitamin D, wound healing, bone regeneration, and trauma. Original and review articles published between 2010 and 2024 were analysed. The synthesis confirmed the key role of vitamin D in regulating cell proliferation, angiogenesis, extracellular matrix synthesis, and inflammation modulation. Clinical data indicate that supplementation is most beneficial for patients with pre-existing deficiency, significantly reducing the risk of complications and improving healing parameters. Groups at particular risk of deficiency requiring monitoring include the elderly, burn victims, diabetics, individuals with dark skin phototypes, and those with malabsorption disorders. For patients with normal or high baseline 25(OH)D levels, the benefits of supplementation are limited or insignificant. Optimising vitamin D levels is a significant, modifiable factor supporting tissue healing, especially in deficient patients. Routine assessment of vitamin D status and targeted supplementation in risk groups should be an integral part of comprehensive post-traumatic care.